The report will be delivered in 2-3 business days.

Oncology Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 38 | Published : January 2018 | SKU CODE : 2778 | Format :


Oncology deals with diagnosis, prevention and treatment of cancer diseases. Anti-cancer or anti-neoplastic agents are the drugs that prevent or inhibit or halt the proliferation and maturation of neoplasms, an abnormal growth of tissues commonly referred as tumors. These drugs prevent the growth of malignant tumors by affecting the process of cell division or by damaging the DNA and initiate apoptosis or by preventing the development and spread of neoplastic cells. Several types of cancers that can be treated by oncology drugs are blood cancer, lung cancer, endocrine cancer, bone cancer, gastric cancer, colorectal cancer, skin cancer, breast cancer, pancreatic cancer, prostate cancers, ovarian cancer, ocular cancer and others.

Oncology Drugs Global Market Size

The global oncology drugs market was valued around $126 billion in 2017. North America was the largest region in the oncology drugs market in 2017, accounting for around 30% of the total market. The USA was the largest country in the market accounting for around 25% of the total market.

Oncology Drugs Global Market Trend

Companies in the oncology drug market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive oncology drug market, companies are developing innovative products as well as sharing skills and expertise with other companies.

The major players in the global oncology drugs market are F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences, Inc., Bayer AG and Takeda Pharmaceuticals. F. Hoffmann-La Roche Ltd. was the largest company in the oncology drugs market.

The countries covered in the global oncology drugs market are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Oncology Drugs Global Market Segmentation

The oncology drugs market in this report is segmented into oncology drugs, drugs for blood cancer, breast cancer, cervical cancer, lung cancer, prostate cancer, kidney cancer, colorectal cancer, thyroid cancer, non-small cell lung cancer, gastric cancer, brain tumor, pancreatic cancer, skin cancer, ovarian cancer, bladder cancer and others.
Blood cancer share attributes to large population of cancer patients suffering from various types of blood cancers such as Leukemia, Lymphoma, and Myeloma.
Breast cancer increases in aging population, improvement in the survival rates with early diagnosis, access to medical care and progressive improvement in treatment strategies contribute to the market share.
Cervical cancer contributing to the size of this market include increase in aging population, improved diagnosis for cervical cancer leading to more patients being exposed to treatment.
Lung cancer increases the demand for therapeutics which has contributed to the size of this market.

New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Remdesivir Market Global Report 2020-30: COVID 19 Growth and Change
View Report
Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)